{"id":45588,"date":"2022-06-28T15:01:43","date_gmt":"2022-06-28T13:01:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/"},"modified":"2022-06-28T15:01:43","modified_gmt":"2022-06-28T13:01:43","slug":"mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/","title":{"rendered":"MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth"},"content":{"rendered":"
\n

\nThe partnership will help MMS expand its award-winning services to pharma and biotech companies and extend MMS\u2019 leadership in data-focused clinical research services<\/i>\n<\/p>\n

CANTON, Mich.–(BUSINESS WIRE)–MMS Holdings Inc. (\u201cMMS\u201d or the \u201cCompany\u201d), a leading data-focused contract research organization (\u201cCRO\u201d), today announced that Lindsay Goldberg, a leading family and founder-focused private equity firm, has completed an agreement to invest in the Company alongside MMS Founder and CEO, Dr. Uma Sharma, who will maintain a significant ownership interest.\n<\/p>\n

\nMMS is an award-winning, global, data-focused CRO supporting pharmaceutical and biotech companies. Headquartered in Canton, Michigan, with over 800 global colleagues across four continents, MMS couples a science-first approach with its best-in-class customer service to provide the quality regulatory and data-focused services necessary to support high-impact clinical research and to facilitate successful new therapy approvals. MMS\u2019 industry-leading capabilities are uniquely well aligned to the challenges created by the increasing complexity of clinical research data and the Company has a differentiated track record of leading successful regulatory submissions, having completed more than 50 submissions in the last five years.\n<\/p>\n

\n\u201cWe are delighted to have found a private equity partner who both values our unique culture and who can help us scale our business, as we grow to be the best in class,\u201d said MMS Founder and CEO Dr. Uma Sharma. \u201cLindsay Goldberg has decades of experience in actively building healthcare businesses and working collaboratively with founders. We are proud to have a partner with a shared vision and deep experience in successfully growing founder-led businesses.\u201d\n<\/p>\n

\n\u201cWe\u2019re proud to partner with Dr. Sharma to help accelerate the growth of MMS, a leader in data-focused CRO services known internationally for its scientific approach and differentiated regulatory, biostatistics, data management, medical writing, and pharmacovigilance capabilities,\u201d said Lindsay Goldberg Principal, Peter Nurnberg. \u201cWe recognize that MMS\u2019 globally cohesive culture is foundational to its reputation for exceptional customer service and we will continue to foster this customer-centric focus.\u201d\n<\/p>\n

\nMichael Dees, Managing Partner at Lindsay Goldberg, added, \u201cMMS is a world-changing organization. Dr. Sharma\u2019s team is delivering critical services to leading pharma and biotech companies and thereby improving their chances of successful drug submissions. Through our partnership, we can help accelerate the Company\u2019s momentum and growth, while maintaining a focus on producing the highest quality, scientifically-sound deliverables.\u201d\n<\/p>\n

\nABOUT MMS
\n
<\/b>MMS is an award-winning, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the Company has been recognized as a leading CRO in Global Health & Pharma\u2019s international awards programs for the last three consecutive years. For more information, visit www.mmsholdings.com<\/a>.\n<\/p>\n

\nABOUT LINDSAY GOLDBERG
\n
<\/b>Lindsay Goldberg is a private investment firm that focuses on partnering with families, founders and management teams seeking to actively build their businesses. Since 2001, Lindsay Goldberg has raised more than $17 billion of equity capital and has invested in over 50 platform companies and over 250 follow-on opportunities. The firm focuses on three industries that typically demonstrate resilience across economic cycles, including industrials, healthcare, and services (business, government, and financial services), in the U.S., Canada, and Western Europe. Lindsay Goldberg takes a relationship driven approach to investing and is supported by its global network of affiliate partners. For more information about Lindsay Goldberg, please visit www.lindsaygoldbergllc.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contacts<\/b>
MMS Holdings
\n
Lisa James
\n
media@mmsholdings.com<\/a>\n<\/p>\n

\nLindsay Goldberg
\n
Cathleen Ellsworth
\n
LGCommunications@lindsaygoldbergllc.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The partnership will help MMS expand its award-winning services to pharma and biotech companies and extend MMS\u2019 leadership in data-focused clinical research services CANTON, Mich.–(BUSINESS WIRE)–MMS Holdings Inc. (\u201cMMS\u201d or the \u201cCompany\u201d), a leading data-focused contract research organization (\u201cCRO\u201d), today announced that Lindsay Goldberg, a leading family and founder-focused private equity firm, has completed an … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45588","6":"format-standard","7":"category-industry"},"yoast_head":"\nMMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The partnership will help MMS expand its award-winning services to pharma and biotech companies and extend MMS\u2019 leadership in data-focused clinical research services CANTON, Mich.–(BUSINESS WIRE)–MMS Holdings Inc. (\u201cMMS\u201d or the \u201cCompany\u201d), a leading data-focused contract research organization (\u201cCRO\u201d), today announced that Lindsay Goldberg, a leading family and founder-focused private equity firm, has completed an ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-28T13:01:43+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth\",\"datePublished\":\"2022-06-28T13:01:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\\\/\"},\"wordCount\":618,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\\\/\",\"name\":\"MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-06-28T13:01:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/","og_locale":"en_US","og_type":"article","og_title":"MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth - Pharma Trend","og_description":"The partnership will help MMS expand its award-winning services to pharma and biotech companies and extend MMS\u2019 leadership in data-focused clinical research services CANTON, Mich.–(BUSINESS WIRE)–MMS Holdings Inc. (\u201cMMS\u201d or the \u201cCompany\u201d), a leading data-focused contract research organization (\u201cCRO\u201d), today announced that Lindsay Goldberg, a leading family and founder-focused private equity firm, has completed an ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-28T13:01:43+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth","datePublished":"2022-06-28T13:01:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/"},"wordCount":618,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/","url":"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/","name":"MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-06-28T13:01:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mms-holdings-partners-with-lindsay-goldberg-for-its-next-stage-of-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45588","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45588"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45588\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45588"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45588"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}